Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Single Blind Placebo-Controlled Multi-Center Study Comparing Combination Therapy With Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder to Combination Therapy With ADVAIR DISKUS® 100/50 (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder) in Treatment of Subjects With Asthma

NCT03562923 is registered in ClinicalTrials.gov with Amneal Ireland Limited as lead sponsor.

NCT NCT03562923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03562923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Single Blind Placebo-Controlled Multi-Center Study Comparing Combination Therapy With Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder to Combination Therapy With ADVAIR DISKUS® 100/50 (Fluticasone Propionate 100 mcg and Salmeterol 50 mcg Inhalation Powder) in Treatment of Subjects With Asthma
Lead sponsor
Amneal Ireland Limited
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2018
Completion date
June 30, 2019
Enrollment
1,204 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

asthma